Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$558M |
| 2 |
SPDR Gold Trust
GLD
|
+$550M |
| 3 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$519M |
| 4 |
XYZ
Block Inc
XYZ
|
+$436M |
| 5 |
Adobe
ADBE
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.06B |
| 3 |
Starbucks
SBUX
|
+$1.05B |
| 4 |
Qualcomm
QCOM
|
+$734M |
| 5 |
Union Pacific
UNP
|
+$571M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.53% |
| 2 | Healthcare | 10.36% |
| 3 | Financials | 9.14% |
| 4 | Consumer Discretionary | 7.65% |
| 5 | Communication Services | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVH
4001
DELISTED
Delaware Ivy High Income Opportunities Fund
IVH
| $1.3M | ﹤0.01% |
107,308
+18,324
| +21% | +$241K |
|
4002
Seneca Foods Class A
SENEA
$1.13B
| $1.3M | ﹤0.01% |
46,038
+4,440
| +11% | +$141K |
|
4003
Scully Royalty
SRL
$86.5M
| $1.29M | ﹤0.01% |
248,430
+3,238
| +1% | +$16.1K |
|
|
CGO
4004
Calamos Global Total Return Fund
CGO
$128M
| $1.29M | ﹤0.01% |
127,062
-28,215
| -18% | -$329K |
|
4005
Ocular Therapeutix
OCUL
$1.92B
| $1.29M | ﹤0.01% |
324,280
+69,315
| +27% | +$382K |
|
|
DSE
4006
DELISTED
Duff & Phelps Select MLP and Midstream Energy Fund Inc.
DSE
| $1.29M | ﹤0.01% |
32,817
-5,235
| -14% | -$268K |
|
4007
US Commodity Index
USCI
$364M
| $1.29M | ﹤0.01% |
34,317
-2,354
| -6% | -$94.5K |
|
|
AQUA
4008
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1.29M | ﹤0.01% |
134,012
-105,429
| -44% | -$1.22M |
|
4009
UNIFI
UFI
$128M
| $1.28M | ﹤0.01% |
56,053
-42,516
| -43% | -$1.07M |
|
|
DNI
4010
DELISTED
Dividend and Income Fund
DNI
| $1.28M | ﹤0.01% |
134,461
-123,348
| -48% | -$1.34M |
|
4011
Winmark
WINA
$1.27B
| $1.28M | ﹤0.01% |
8,049
-14,344
| -64% | -$2.19M |
|
4012
Nicolet Bankshares
NIC
$3.64B
| $1.28M | ﹤0.01% |
26,195
-5,705
| -18% | -$296K |
|
|
MZA
4013
DELISTED
BlackRock MuniYield Arizona Fund, Inc
MZA
| $1.28M | ﹤0.01% |
104,625
+7,544
| +8% | +$93K |
|
4014
CytomX Therapeutics
CTMX
$734M
| $1.27M | ﹤0.01% |
84,379
-11,703
| -12% | -$174K |
|
|
EBSB
4015
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.27M | ﹤0.01% |
88,860
+1,939
| +2% | +$30.5K |
|
4016
Schwab Fundamental International Large Company Index ETF
FNDF
$25.2B
| $1.27M | ﹤0.01% |
50,330
+32,006
| +175% | +$878K |
|
|
ODT
4017
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $1.27M | ﹤0.01% |
90,070
+77,963
| +644% | +$1.21M |
|
4018
iShares Global Clean Energy ETF
ICLN
$2.37B
| $1.27M | ﹤0.01% |
153,386
+4,424
| +3% | +$37.6K |
|
4019
VanEck Low Carbon Energy ETF
SMOG
$132M
| $1.27M | ﹤0.01% |
23,196
+4,436
| +24% | +$249K |
|
4020
PC Connection
CNXN
$2.19B
| $1.26M | ﹤0.01% |
42,521
-34,936
| -45% | -$1.12M |
|
4021
Greif Class B
GEF.B
$4.21B
| $1.26M | ﹤0.01% |
28,493
+81
| +0.3% | +$4.05K |
|
4022
National CineMedia
NCMI
$378M
| $1.26M | ﹤0.01% |
19,488
-39,089
| -67% | -$3.07M |
|
|
CDR
4023
DELISTED
Cedar Realty Trust, Inc
CDR
| $1.26M | ﹤0.01% |
60,880
-11,433
| -16% | -$277K |
|
4024
Vera Bradley
VRA
$96.1M
| $1.26M | ﹤0.01% |
146,869
+53,748
| +58% | +$631K |
|
4025
iShares Core 10+ Year USD Bond ETF
ILTB
$594M
| $1.26M | ﹤0.01% |
21,296
-45,500
| -68% | -$2.64M |
|
Similar funds
Morgan Stanley's Q4 2018 Portfolio in Review
As of Q4 2018, Morgan Stanley held 7,016 positions worth $334B, down 16% from $400B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley withdrew a net $11.7B in Q4 2018, closing 210 positions and reducing 3,411 holdings. Its most notable exit was Praxair Inc, an estimated $398M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Morgan Stanley opened a new position in Linde worth $342M.
- Morgan Stanley's largest Q4 2018 buy was Linde: 2,188,871 shares worth $342M.
- Morgan Stanley added most to People Inc in Q4 2018, an estimated $558M increase.
- Morgan Stanley's biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Morgan Stanley fully exited Praxair Inc in Q4 2018, selling an estimated $398M.
- Morgan Stanley's ten largest holdings make up 14% of its $334B portfolio in Q4 2018.
- Morgan Stanley opened 146 new positions and closed 210 in Q4 2018.
- Morgan Stanley's portfolio value fell 16% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q4 2018, filed 14 Feb 2019.